Vanadate-based transition-state analog inhibitors of Cre-LoxP recombination

Biochemical and Biophysical Research Communications

Volumn 308, Issue 3, 2003, Pages 529-534

  Martin, Shelley S ^a   Wachi, Shinichiro ^a   Baldwin, Enoch P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cre recombinase; DNA cleavage and religation; Half sites recombination; Integrase family; Meta vanadate transition state analogs; Pentacoordinate transition state; Site specific recombination; Type 1B topoisomerase; Tyrosine recombinase

Indexed keywords

CRE RECOMBINASE; DNA TOPOISOMERASE; INTEGRASE; RECOMBINASE; UNCLASSIFIED DRUG; VANADIC ACID;

ARTICLE; BACTERIOPHAGE P1; DNA BINDING; DNA CLEAVAGE; DNA RECOMBINATION; DNA STRAND; HOLLIDAY JUNCTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION;

EID: 0042665972     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01437-2     Document Type: Article

References (30)

1. Sternberg N. Bacteriophage P1 site-specific recombination. III. Strand exchange during recombination at lox sites. J. Mol. Biol. 1981;603-608.
2. Hoess R.H., Ziese M., Sternberg N. P1 site-specific recombination: nucleotide sequence of the recombining sites. Proc. Natl. Acad. Sci. USA. 1982;3398-3402.
3. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis. 2000;99-109.
4. Cheng C., Kussie P., Pavletich N., Shuman S. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell. 1998;841-850.
5. Sherratt D.J., Wigley D.B. Conserved themes but novel activities in recombinases and topoisomerases. Cell. 1998;149-152.
6. Hoess R., Wierzbicki A., Abremski K. Isolation and characterization of intermediates in site-specific recombination. Proc. Natl. Acad. Sci. USA. 1987;6840-6844.
7. Van Duyne G.D. A structural view of cre-loxp site-specific recombination. Annu. Rev. Biophys. Biomol. Struct. 2001;87-104.
8. Krogh B.O., Shuman S. Proton relay mechanism of general acid catalysis by DNA topoisomerase IB. J. Biol. Chem. 2002;5711-5714.
9. Krogh B.O., Shuman S. Catalytic mechanism of DNA topoisomerase IB. Mol. Cell. 2000;1035-1041.
10. Wlodawer A., Miller M., Sjolin L. Active site of RNase: neutron diffraction study of a complex with uridine vanadate, a transition-state analog. Proc. Natl. Acad. Sci. USA. 1983;3628-3631.
11. Stankiewicz P.J., Gresser M.J. Inhibition of phosphatase and sulfatase by transition-state analogues. Biochemistry. 1988;206-212.
12. Kostrewa D., Choe H.W., Heinemann U., Saenger W. Crystal structure of guanosine-free ribonuclease T1, complexed with vanadate (V), suggests conformational change upon substrate binding. Biochemistry. 1989;7592-7600.
13. Lindqvist Y., Schneider G., Vihko P. Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. Eur. J. Biochem. 1994;139-142.
14. Smith C., Rayment I. X-ray structure of the magnesium(II). ADP-vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 Å resolution. Biochemistry. 1996;5404-5417.
15. Denu J., Lohse D., Vijayalakshmi J., Saper M., Dixon J. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc. Natl. Acad. Sci. USA. 1996;2493-2498.
16. Holtz K., Stec B., Kantrowitz E. A model of the transition state in the alkaline phosphatase reaction. J. Biol. Chem. 1999;8351-8354.
17. Rupert P.B., Massey A.P., Sigurdsson S.T., Ferre-D'Amare A.R. Transition state stabilization by a catalytic RNA. Science. 2002;1421-1424.
18. Davies D.R., Interthal H., Champoux J.J., Hol W.G. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J. Mol. Biol. 2002;917-932.
19. Davies D.R., Interthal H., Champoux J.J., Hol W.G. Crystal structure of a transition state mimic for tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem. Biol. 2003;139-147.
20. Schramm V. Enzymatic transition states and transition state analog design. Annu. Rev. Biochem. 1998;693-720.
21. Stankiewicz P., Tracey A., Crans D. Inhibition of phosphate-metabolizing enzymes by oxovanadium(V) complexes. Met. Ions Biol. Syst. 1995;287-324.
22. Gordon J. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 1991;477-482.
23. Woods K.C., Martin S.S., Chu V.C., Baldwin E.P. Quasi-equivalence in site-specific recombinase structure and function: crystal structure and activity of trimeric cre recombinase bound to a three-way lox DNA junction. J. Mol. Biol. 2001;49-69.
24. Martin S.S., Pulido E., Chu V.C., Lechner T.S., Baldwin E.P. The order of strand exchanges in Cre-LoxP recombination and its basis suggested by the crystal structure of a Cre-LoxP Holliday junction complex. J. Mol. Biol. 2002;107-127.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;680-685.
26. Martin S.S., Chu V.C., Baldwin E.P. Modulation of the active complex assembly and turnover rate by protein-DNA interactions in Cre-LoxP recombination. Biochemistry. 2003;6814-6826.
27. Hoess R.H., Abremski K. Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system. J. Mol. Biol. 1985;351-362.
28. Shaikh A.C., Sadowski P.D. The Cre recombinase cleaves the lox site in trans. J. Biol. Chem. 1997;5695-5702.
29. Wolfenden R. Transition state analog inhibitors and enzyme catalysis. Annu. Rev. Biophys. Bioeng. 1976.
30. Williams J.W., Morrison J.F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 1979;437-467.